Download Fortebet App FDA approves world's first intravenous drug for migraine prevention Detained for 10 days and fined 500 yuan! The latest prog ...

Giovanili beach volley Breaking news! Chinese scientists reveal the mechanism of CAR-T cells triggering cytokine release syndrome Can Pfizer's co ...

INR:8987. lottery ka fax Cathay Biopharma's application for listing on the Science and Technology Innovation Board was accepted and it had failed to enter Nasdaq S ...

A recent review published in eGastroenterology discusses recent advancements in understanding alcohol-associated liver ...

Chugai Pharma receives Japanese regulatory approval for Lunsumio for intravenous infusion for relapsed/refractory follicular lymphoma: Tokyo Saturday, December 28, 2024, 13:00 Hrs ...

The following is a summary of “REmoval of cytokines during CArdiac surgery (RECCAS): a randomised controlled trial,” published in the December 2024 issue of Critical Care by Hohn et al.

CURE® highlights some top stories from the ASH Annual Meeting, focusing on B-cell acute lymphoblastic leukemia, multiple ...

The advent of cellular therapies, such as chimeric antigen receptor T-cell therapy, has revolutionized the field of ...

Chimeric antigen receptor T-cell or CAR T therapy shows promise for patients with refractory or relapsing B-cell lymphomas.

The first patient was enrolled in a phase 3 trial for patients with non-metastatic uveal melanoma to either receive Kimmtrak ...